The biotech Altos Labs has exited stealth mode with top-tier talent and $3 billion in funding with a broad mission of promoting homeostasis in cells to reverse disease, injury and disability. In other words, the company aims to use biotechnology to fight aging and disease, as early media reports have suggested. In a press release, Altos…